Order Article Reprints

Puertas B, González-Calle V, Sobejano-Fuertes E, Escalante F, Queizán JA, Bárez A, Labrador J, Alonso-Alonso JM, García de Coca A, Cantalapiedra A, et al. Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma. Cancers. 2023; 15(5):1558. https://doi.org/10.3390/cancers15051558

Puertas, Borja, Verónica González-Calle, Eduardo Sobejano-Fuertes, Fernando Escalante, José A. Queizán, Abelardo Bárez, Jorge Labrador, José María Alonso-Alonso, Alfonso García de Coca, Alberto Cantalapiedra, and et al. 2023. "Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma" Cancers 15, no. 5: 1558. https://doi.org/10.3390/cancers15051558

Puertas, B., González-Calle, V., Sobejano-Fuertes, E., Escalante, F., Queizán, J. A., Bárez, A., Labrador, J., Alonso-Alonso, J. M., García de Coca, A., Cantalapiedra, A., Villaescusa, T., Aguilar-Franco, C., Alejo-Alonso, E., Rey-Bua, B., López-Corral, L., García-Sanz, R., Puig, N., Gutiérrez, N. C., & Mateos, M.-V. (2023). Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma. Cancers, 15(5), 1558. https://doi.org/10.3390/cancers15051558